aromatase inhibitor
What Is the Benefit of Extending AIs Beyond Five Years?
Chicago—Extending aromatase inhibitor (AI) therapy beyond five years lowered the risk for recurrence by 34% ...
JULY 12, 2016
No Increased Risk for Fatal CVD Events With Aromatase Inhibitors
For older women diagnosed with breast cancer, cardiovascular disease is a cause of death that is important yet ...
APRIL 22, 2016
Load more